TAG:
care contracts
Another Lab Acquisition: LabCorp To Buy DIANON
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: Laboratory Corporation of America Holdings will pay almost $598 million to buy DIANON Systems, Inc. of Stratford, Connecticut. With this move, anatomic pathology becomes a high profile growth target for LabCorp. During the past eight years, DIANON Systems has built a national…
Why DIANON Sale Alters Anatomic Path Market
By Robert Michel | From the Volume IX No. 16 – November 18, 2002 Issue
CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic p…
Why Do Michigan Hospital Labs “Have it Together?
By R. Lewis Dark | From the Volume IX No. 15 – October 28, 2002 Issue
WHAT MAKES HOSPITAL LABORATORY ADMINISTRATORS AND PATHOLOGISTS in Michigan so willing to be both innovative and collaborative in creating sophisticated and financially successful regional laboratory organizations? As you will read on pages 2-6, Michigan Co-Tenancy Laboratory (MCL), …
Two Blood Brothers Use “Free Testing” Strategy
By Robert Michel | From the Volume IX No. 12 – August 26, 2002 Issue
CEO SUMMARY: It’s a business strategy that Quest Diagnostics Incorporated and Laboratory Corporation of America use in selected areas where they have lost exclusive managed care contracts to regional lab competitors. In order to retain access to a physician’s fee-for-service testing b…
Will “Free Testing” Ploy Financially Affect Labs?
By Robert Michel | From the Volume IX No. 12 – August 26, 2002 Issue
CEO SUMMARY: It’s a marketing scheme which public lab companies have quietly used for years. Now there is evidence that the use of “Waiver of Charges to Managed Care Patients” (free testing) seems to be on the increase, raising new questions about how and why competitive practices a…
Is Physicians’ Office Testing Evolving Toward an Oligopoly?
By Robert Michel | From the Volume IX No. 7 – May 13, 2002 Issue
CEO SUMMARY: One of the most unpopular industries with consumers is the airline industry. At the national level, it is an oligopoly—dominated by seven carriers. But in many cities, it is a monopoly, with one airline flying 80% of the seats in and out of town. Ongoing consolidation of re…
Quest Pays $1.1 Billion To Acquire Unilab Corp.
By Robert Michel | From the Volume IX No. 6 – April 22, 2002 Issue
CEO SUMMARY: Quest Diagnostics Incorporated is showing its muscle. The dust had hardly settled on its $500 million acquisition of American Medical Laboratories when the lab industry’s behemoth announced that it would pay $1.1 billion to buy Unilab, by far the largest lab testing company…
Michigan Lab Network Wins Major HMO Deal
By Robert Michel | From the Volume IX No. 4 – March 11, 2002 Issue
CEO SUMMARY: By winning the contract for Health Alliance Plan (HAP), Joint Venture Hospital Laboratories (JVHL) captured another major exclusive managed care contract for lab testing services in Southeast Michigan. Its victory demonstrates that local hospital lab outreach programs can com…
Clinical Labs Discover Benchmarking
By R. Lewis Dark | From the Volume IX No. 1 – January 7, 2002 Issue
IN OUR MANY YEARS OF SERVICE to the clinical lab industry and the pathology profession, THE DARK REPORT has consistently been first to identify important trends and explain their relevance to those responsible for managing the nation’s laboratories. Back in 1995, we predicted that the (then) thre…
Certain Medicare Lab Reforms May Make It Through Congress
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
ONE CONSEQUENCE of the terrorist attacks on September 11 is that proposed reforms to Medicare lab reimbursement policies have assumed a lesser priority with the current Congress. Despite that fact, Congress must still address the day-to-day requirements of managing government functions. Thus, there …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized